Nanoscope Therapeutics Announces Five New Clinical and Scientific Advisory Board Appointments

/PRNewswire/ -- Nanoscope Therapeutics Inc, a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced...

Related Keywords

Boston ,Massachusetts ,United States ,California ,Bedford ,Texas ,University Of Texas Southwestern Medical Center ,Samarendra Mohanty ,Jeff Heier ,Vittorio Porciatti ,Dan Eramian ,Stephen Kaminsky ,Davids Boyer ,Peter Kaiser ,Thomas Yorio ,Steven Gray ,Paul Yang ,Srinivasr Sadda ,Stephenh Tsang ,Drug Administration For Retinitis Pigmentosa ,Professor Of Research ,Weill Cornell Medical College ,Ocular Research ,Nanoscope Therapeutics Inc ,Vitreous Associates Medical Group ,Opus Biotech Communications ,Tufts University School Of Medicine ,Cleveland Clinic Cole Eye Institute ,Scientific Advisory Board ,Nanoscope President ,Senior Partner ,Retina Vitreous Associates Medical Group ,Medical Director ,Ophthalmic Consultants ,Assistant Professor ,Tufts University School ,Cleveland Clinic ,Cole Eye Institute ,Genetic Medicine ,Associate Director ,Gene Therapy Core ,Weill Cornell Medical ,Associate Professor ,Texas Southwestern Medical Center ,Viral Vector ,Michael Singer ,Sai Chavala ,Drug Administration ,Retinitis Pigmentosa ,Nanoscope Therapeutics ,Health Care Amp Hospitals ,Medical Equipment ,Medical Pharmaceuticals ,Biotechnology ,Nanotechnology ,Computer Amp Electronics ,Personnel Announcements ,